Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma.
about
Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid CarcinomaImaging of thyroid carcinoma with CT and MRI: approaches to common scenariosF18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysisEvaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer.Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.Positron emission tomography and positron emission tomography-CT evaluation for recurrent papillary thyroid carcinoma: meta-analysis and literature review.The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.American Thyroid Association statement on preoperative imaging for thyroid cancer surgery.The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Prognostication, Diagnosis, and Management of Thyroid Carcinoma.The contributions of gamma probe to lesion detectability and surgical safety in recurrent thyroid cancer at risk.Recurrent differentiated thyroid cancer: to cut or burn.Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.
P2860
Q26765093-E1621A5C-BF57-4F42-9313-84C9BFAD3F75Q26995608-AF1AB2E8-3DA8-4732-AC8E-BA91472AB718Q35688657-AAA56A8D-8E48-4C32-86AD-DB02F6DFAF10Q36030298-E4EE23F4-478D-48A6-857A-C519A162CB72Q36070835-0A3DC551-DD98-466A-9E10-F26E509DACA7Q36325942-82E915E4-7869-4D3B-84AE-9CCE5874146EQ37776221-14603FF6-B29F-4326-B216-6CC75ECFADDAQ37850202-6DB86BB5-5304-4F69-88C0-F7BB72CD40D8Q38246037-224FA1B7-EAA0-480D-AF5E-D2D5EC751694Q38658588-41351176-6935-4C3D-8F55-8C408EA0A435Q42579889-622C64A6-8C67-451B-9E72-3C203C6D07D1Q42907534-777AB724-99F1-4B72-B3F7-9192F15EA14DQ44448524-065B1316-AB06-43F7-BB0D-F84813B41D7DQ48318143-04B85739-5C8B-4760-8B14-6C18EE7A4372Q53575024-C3808B31-2F96-4E41-9684-3472CB64203F
P2860
Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Clinical usefulness of positro ...... n recurrent thyroid carcinoma.
@en
Clinical usefulness of positro ...... n recurrent thyroid carcinoma.
@nl
type
label
Clinical usefulness of positro ...... n recurrent thyroid carcinoma.
@en
Clinical usefulness of positro ...... n recurrent thyroid carcinoma.
@nl
prefLabel
Clinical usefulness of positro ...... n recurrent thyroid carcinoma.
@en
Clinical usefulness of positro ...... n recurrent thyroid carcinoma.
@nl
P2093
P356
P1433
P1476
Clinical usefulness of positro ...... n recurrent thyroid carcinoma.
@en
P2093
Ali Razfar
Apostolos Christopoulos
Dwight E Heron
Edward J Escott
Robert L Ferris
Shane O Lebeau
Steven P Hodak
P304
P356
10.1001/ARCHOTO.2009.215
P577
2010-02-01T00:00:00Z